PubMed

Attenuation of prazosin effect on cardiac output in chronic heart failure.

Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.

Ann Intern Med. 1979 Sep;91(3):345-9.PMID: 475164 [PubMed - indexed for MEDLINE]Related articles

Development of pharmacodynamic tolerance to prozosin in congestive heart failure.

Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.

Am J Cardiol. 1979 Nov;44(6):1178-82.PMID: 495512 [PubMed - indexed for MEDLINE]Related articles

Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.

Feldman RC, Ball RM, Winchester MA, Jaillon P, Kates RE, Harrison DC.

Am Heart J. 1981 May;101(5):534-40.PMID: 7223593 [PubMed - indexed for MEDLINE]Related articles

Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.

Chatterjee K, Ports TA, Arnold S, Brundage B, Parmley W.

Br Heart J. 1979 Dec;42(6):657-63.PMID: 534582 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.

Yui Y, Sakurai T, Nakajima H, Kawai C.

Jpn Circ J. 1984 Apr;48(4):365-72.PMID: 6371282 [PubMed - indexed for MEDLINE]Related articles

Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.

Elkayam U, Lejemtel TH, Mathur M, Ribner HS, Frishman WH, Strom J, Sonnenblick EH.

Am J Cardiol. 1979 Sep;44(3):540-5. No abstract available. PMID: 474434 [PubMed - indexed for MEDLINE]Related articles

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.

Chatterjee K, Ports TA, Brundage BH, Massie B, Holly AN, Parmley WW.

Ann Intern Med. 1980 May;92(5):600-4.PMID: 7386999 [PubMed - indexed for MEDLINE]Related articles

Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.

Bertel O, Burkart F, Bühler FR.

Am Heart J. 1981 May;101(5):529-33.PMID: 7223592 [PubMed - indexed for MEDLINE]Related articles

Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.

Nakajima H, Yui Y, Kawashita K, Yoshida A, Kawai C.

Jpn Circ J. 1982 May;46(5):468-72.PMID: 7077811 [PubMed - indexed for MEDLINE]Related articles

Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.

Hayashi H, Sassa H, Oba M, Fukaya T, Okubo M, Niwa T, Matsui E.

Jpn Heart J. 1980 Nov;21(6):827-36.PMID: 7007686 [PubMed - indexed for MEDLINE]Related articles

Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.

Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH.

Clin Pharmacol Ther. 1981 Jul;30(1):23-30.PMID: 7237894 [PubMed - indexed for MEDLINE]Related articles

Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.

Rubin SA, Chatterjee K, Gelberg HJ, Ports TA, Brundage BH, Parmley WW.

Am J Cardiol. 1979 Apr;43(4):810-5.PMID: 425918 [PubMed - indexed for MEDLINE]Related articles

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.

Awan NA, Miller RR, DeMaria AN, Maxwell KS, Neumann A, Mason DT.

Circulation. 1977 Sep;56(3):346-54.PMID: 884789 [PubMed - indexed for MEDLINE]Related articles

Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.

Cohn K, Selzer A, Kersh ES, Karpman LS, Goldschlager N.

Am J Cardiol. 1975 Apr;35(4):461-8.PMID: 1119395 [PubMed - indexed for MEDLINE]Related articles

The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).

Kluger J, Cody RJ, Laragh JH.

Am J Cardiol. 1982 May;49(7):1667-74.PMID: 7044087 [PubMed - indexed for MEDLINE]Related articles

Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.

Packer M, Medina N, Yushak M.

Am J Cardiol. 1986 Jun 1;57(15):1323-7.PMID: 3521251 [PubMed - indexed for MEDLINE]Related articles

Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.

Packer M, Medina N, Yushak M.

J Am Coll Cardiol. 1986 Mar;7(3):671-80.PMID: 2869077 [PubMed - indexed for MEDLINE]Related articles

The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.

Harper RW, Claxton H, Middlebrook K, Anderson S, Pitt A.

Med J Aust. 1980 Jul 26;2 Suppl 1:36-8. No abstract available. PMID: 7421721 [PubMed - indexed for MEDLINE]Related articles

Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.

Cavero PG, De Marco T, Kwasman M, Lau D, Liu M, Chatterjee K.

J Am Coll Cardiol. 1992 Dec;20(7):1542-8.PMID: 1452928 [PubMed - indexed for MEDLINE]Related articles

Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.

Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV.

Ann Intern Med. 1981 Jul;95(1):5-13.PMID: 7247126 [PubMed - indexed for MEDLINE]Related articles